Search Results
Slidesets
Expanding CHB Treatment Criteria with Nucs as Prelude of Novel Curative Therapies? - Harry Janssen, MD, PhD
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Efficacy and Safety of Targeting PD-L1 with Monoclonal Antibodies - Jinzi J. Wu, PhD
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Durability of Response After DAA Therapies - Fabien Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Does siRNA Restore Host Control and Could it Lead to Sustained HBsAg Suppression? - Michael J. Sofia, PhD
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Discrimination of Integrated vs. cccDNA Derived HBsAg - Chloe Thio, MD
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Bepirovirsen in Combination with Peg-IFN and Other Molecules - Stuart Kendrick, MD, PhD, MRCP
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Balance of Response and Adverse Events in Immunotherapy for CHB - Jordan Feld, MD, MPH
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Are We Only Able to Suppress HDV or is Cure in Reach? - Pietro Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Anti-HBs Monoclonal Antibodes in Nuc-naïve and Combo Therapies - Carey Hwang, MD, PhD
Presented at:
International Workshop on HBV Cure 2023